Back to top

Image: Bigstock

Brixmor (BRX) Reports Q3 Earnings: What Key Metrics Have to Say

Read MoreHide Full Article

Brixmor Property (BRX - Free Report) reported $307.31 million in revenue for the quarter ended September 2023, representing a year-over-year increase of 0.8%. EPS of $0.50 for the same period compares to $0.26 a year ago.

The reported revenue represents a surprise of -0.39% over the Zacks Consensus Estimate of $308.53 million. With the consensus EPS estimate being $0.50, the company has not delivered EPS surprise.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Brixmor performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Revenues- Rental income: $307.12 million compared to the $308.50 million average estimate based on five analysts. The reported number represents a change of +0.8% year over year.
  • Revenues- Other revenues: $0.20 million versus $0.43 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +92.2% change.
  • Income (loss) attributable to common stockholders- Diluted: $0.21 compared to the $0.21 average estimate based on five analysts.
View all Key Company Metrics for Brixmor here>>>

Shares of Brixmor have returned -4.3% over the past month versus the Zacks S&P 500 composite's -3.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Brixmor Property Group Inc. (BRX) - free report >>

Published in